| 1.5 |
4.6 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 1.3 |
5.1 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
| 1.1 |
11.6 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 1.0 |
4.1 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 1.0 |
6.0 |
GO:0032196 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
| 1.0 |
4.9 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.9 |
2.8 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.9 |
2.7 |
GO:0070671 |
response to interleukin-12(GO:0070671) |
| 0.9 |
4.3 |
GO:0021856 |
cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
| 0.8 |
3.4 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.8 |
2.5 |
GO:0030421 |
defecation(GO:0030421) |
| 0.8 |
3.3 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.8 |
3.1 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.8 |
3.8 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.7 |
4.5 |
GO:0051987 |
positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.7 |
2.2 |
GO:0048007 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.7 |
2.2 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.7 |
3.4 |
GO:0060809 |
mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.7 |
2.0 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.7 |
4.6 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.6 |
1.9 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.6 |
3.2 |
GO:1902623 |
negative regulation of neutrophil migration(GO:1902623) |
| 0.6 |
1.8 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.6 |
0.6 |
GO:1902524 |
positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 0.6 |
1.2 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.6 |
2.4 |
GO:1901894 |
regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.6 |
1.7 |
GO:1904956 |
regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 0.6 |
1.7 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.6 |
1.7 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.6 |
2.2 |
GO:1901204 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 0.6 |
2.2 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.6 |
1.7 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.5 |
1.6 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.5 |
1.6 |
GO:0070543 |
response to linoleic acid(GO:0070543) |
| 0.5 |
3.1 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.5 |
1.5 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.5 |
2.5 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.5 |
1.5 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.5 |
1.0 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.5 |
1.5 |
GO:2001187 |
positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.5 |
2.5 |
GO:0038027 |
apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 0.5 |
2.5 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.5 |
2.5 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.5 |
2.4 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.5 |
0.5 |
GO:0060252 |
positive regulation of glial cell proliferation(GO:0060252) |
| 0.5 |
2.4 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.5 |
1.4 |
GO:0034241 |
positive regulation of macrophage fusion(GO:0034241) regulation of osteoclast proliferation(GO:0090289) |
| 0.5 |
2.4 |
GO:0051309 |
female meiosis chromosome separation(GO:0051309) |
| 0.5 |
1.4 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.5 |
1.4 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.5 |
0.5 |
GO:1904192 |
cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 0.5 |
1.4 |
GO:0021998 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
| 0.5 |
2.3 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.4 |
0.4 |
GO:0033092 |
positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.4 |
1.8 |
GO:1902990 |
mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.4 |
4.4 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.4 |
0.9 |
GO:1902022 |
L-lysine transport(GO:1902022) |
| 0.4 |
0.9 |
GO:1901079 |
positive regulation of relaxation of muscle(GO:1901079) |
| 0.4 |
0.4 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 0.4 |
5.1 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.4 |
1.3 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.4 |
1.3 |
GO:0050713 |
negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.4 |
1.2 |
GO:1904170 |
regulation of bleb assembly(GO:1904170) |
| 0.4 |
0.4 |
GO:0033127 |
regulation of histone phosphorylation(GO:0033127) |
| 0.4 |
2.4 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.4 |
1.2 |
GO:0045004 |
DNA replication proofreading(GO:0045004) |
| 0.4 |
1.2 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.4 |
2.7 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.4 |
2.3 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.4 |
1.1 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.4 |
2.3 |
GO:1900225 |
NLRP3 inflammasome complex assembly(GO:0044546) regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
| 0.4 |
0.4 |
GO:0072106 |
regulation of branch elongation involved in ureteric bud branching(GO:0072095) regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.4 |
3.0 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.4 |
1.5 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.4 |
1.1 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.4 |
1.1 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.4 |
1.1 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) |
| 0.4 |
0.7 |
GO:0031554 |
regulation of DNA-templated transcription, termination(GO:0031554) |
| 0.4 |
0.4 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 0.4 |
0.4 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.4 |
5.9 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.4 |
0.4 |
GO:0007044 |
cell-substrate junction assembly(GO:0007044) |
| 0.4 |
0.7 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.4 |
1.1 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.4 |
0.4 |
GO:0072173 |
metanephric tubule morphogenesis(GO:0072173) |
| 0.4 |
0.4 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.4 |
1.1 |
GO:0042320 |
regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
| 0.4 |
1.8 |
GO:0034441 |
plasma lipoprotein particle oxidation(GO:0034441) |
| 0.4 |
3.2 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.4 |
1.8 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.3 |
0.7 |
GO:1904659 |
glucose transmembrane transport(GO:1904659) |
| 0.3 |
3.5 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.3 |
1.4 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.3 |
1.0 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.3 |
1.4 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.3 |
1.0 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.3 |
0.7 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.3 |
1.4 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.3 |
1.0 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.3 |
0.3 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 0.3 |
2.3 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.3 |
0.7 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.3 |
5.6 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.3 |
2.6 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.3 |
0.3 |
GO:0034239 |
regulation of macrophage fusion(GO:0034239) |
| 0.3 |
1.3 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.3 |
1.0 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.3 |
0.7 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.3 |
0.3 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.3 |
1.9 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.3 |
0.6 |
GO:2000790 |
regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.3 |
1.0 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
| 0.3 |
1.3 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.3 |
1.6 |
GO:0072530 |
purine-containing compound transmembrane transport(GO:0072530) |
| 0.3 |
6.7 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.3 |
1.6 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.3 |
0.6 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 0.3 |
1.6 |
GO:2000258 |
negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
| 0.3 |
1.9 |
GO:0086023 |
adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
| 0.3 |
1.9 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.3 |
0.6 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.3 |
0.6 |
GO:0038095 |
Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.3 |
2.5 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.3 |
0.9 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.3 |
2.2 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.3 |
0.9 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.3 |
0.9 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 0.3 |
0.9 |
GO:0003289 |
endocardial cushion fusion(GO:0003274) atrial septum primum morphogenesis(GO:0003289) |
| 0.3 |
0.9 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.3 |
0.9 |
GO:2000314 |
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.3 |
1.5 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.3 |
2.1 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.3 |
12.0 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.3 |
0.3 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.3 |
0.9 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.3 |
2.9 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.3 |
3.2 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.3 |
0.3 |
GO:1903463 |
regulation of mitotic cell cycle DNA replication(GO:1903463) |
| 0.3 |
0.9 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.3 |
1.2 |
GO:2000158 |
positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.3 |
3.2 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.3 |
3.5 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.3 |
2.0 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.3 |
0.9 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.3 |
0.9 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.3 |
0.9 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.3 |
0.8 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.3 |
0.3 |
GO:0045358 |
negative regulation of interferon-beta biosynthetic process(GO:0045358) |
| 0.3 |
2.0 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.3 |
0.6 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.3 |
1.4 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.3 |
0.6 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.3 |
1.7 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.3 |
0.3 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.3 |
1.9 |
GO:0007501 |
mesodermal cell fate specification(GO:0007501) |
| 0.3 |
0.6 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.3 |
0.8 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.3 |
1.1 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.3 |
0.3 |
GO:2000426 |
negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.3 |
0.3 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.3 |
3.0 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.3 |
1.3 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.3 |
0.3 |
GO:0048850 |
hypophysis morphogenesis(GO:0048850) |
| 0.3 |
0.8 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.3 |
1.6 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.3 |
2.6 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.3 |
1.0 |
GO:0002827 |
positive regulation of T-helper 1 type immune response(GO:0002827) |
| 0.3 |
0.8 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 0.3 |
1.0 |
GO:0002248 |
connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
| 0.3 |
0.3 |
GO:0021747 |
cochlear nucleus development(GO:0021747) |
| 0.3 |
0.3 |
GO:1902730 |
positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.3 |
1.3 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.3 |
0.5 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.3 |
1.0 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.3 |
0.3 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.3 |
0.8 |
GO:0050904 |
diapedesis(GO:0050904) |
| 0.3 |
0.5 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.3 |
2.3 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.3 |
0.8 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.3 |
2.5 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.3 |
0.8 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.3 |
0.8 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.3 |
1.5 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.2 |
1.5 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.2 |
1.0 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.2 |
0.5 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.2 |
0.2 |
GO:2000542 |
negative regulation of gastrulation(GO:2000542) |
| 0.2 |
0.7 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.2 |
1.2 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.2 |
0.5 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.2 |
1.0 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.2 |
1.5 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.2 |
0.7 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 |
0.2 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.2 |
1.0 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 0.2 |
0.2 |
GO:0003308 |
negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.2 |
0.7 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.2 |
2.2 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.2 |
1.5 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.2 |
1.0 |
GO:1904393 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
| 0.2 |
0.7 |
GO:0090324 |
negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.2 |
4.1 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.2 |
0.2 |
GO:0038065 |
collagen-activated signaling pathway(GO:0038065) |
| 0.2 |
2.4 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.2 |
0.5 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.2 |
0.5 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.2 |
2.4 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.2 |
1.4 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.2 |
6.8 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.2 |
3.1 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.2 |
0.9 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.2 |
1.4 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.2 |
0.7 |
GO:0048687 |
positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
| 0.2 |
0.7 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) odontoblast differentiation(GO:0071895) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.2 |
1.8 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.2 |
0.7 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.2 |
0.9 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.2 |
0.5 |
GO:0016102 |
retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.2 |
0.7 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.2 |
0.5 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.2 |
1.8 |
GO:0016446 |
somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.2 |
1.1 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.2 |
1.3 |
GO:0000279 |
M phase(GO:0000279) |
| 0.2 |
0.7 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.2 |
0.2 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.2 |
0.7 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.2 |
2.2 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.2 |
0.6 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.2 |
3.0 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.2 |
0.6 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.2 |
2.1 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 |
0.2 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.2 |
1.9 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 |
0.2 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.2 |
2.9 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
| 0.2 |
0.4 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.2 |
0.6 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 |
1.4 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.2 |
0.4 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 0.2 |
2.7 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.2 |
0.4 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.2 |
0.8 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.2 |
0.8 |
GO:0046655 |
folic acid metabolic process(GO:0046655) |
| 0.2 |
0.4 |
GO:0071879 |
positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.2 |
2.2 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.2 |
0.2 |
GO:0071033 |
nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 0.2 |
0.4 |
GO:1900020 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.2 |
3.2 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.2 |
0.8 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.2 |
0.2 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.2 |
1.0 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.2 |
1.2 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.2 |
1.6 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.2 |
0.2 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.2 |
1.4 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 0.2 |
2.0 |
GO:1903818 |
positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.2 |
1.0 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.2 |
0.8 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.2 |
1.2 |
GO:1902965 |
regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.2 |
0.6 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.2 |
0.6 |
GO:0071481 |
cellular response to X-ray(GO:0071481) |
| 0.2 |
1.9 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.2 |
0.9 |
GO:0070171 |
negative regulation of tooth mineralization(GO:0070171) |
| 0.2 |
0.6 |
GO:0008594 |
photoreceptor cell morphogenesis(GO:0008594) |
| 0.2 |
1.7 |
GO:0098700 |
neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.2 |
0.4 |
GO:0061341 |
non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
| 0.2 |
0.7 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.2 |
0.4 |
GO:0072182 |
regulation of nephron tubule epithelial cell differentiation(GO:0072182) metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.2 |
0.7 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.2 |
1.7 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.2 |
0.6 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.2 |
0.7 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.2 |
0.6 |
GO:0046073 |
dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 0.2 |
1.7 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.2 |
1.5 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.2 |
0.2 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
| 0.2 |
0.5 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.2 |
1.8 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.2 |
1.4 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.2 |
2.8 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.2 |
1.1 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.2 |
1.2 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.2 |
1.0 |
GO:0043383 |
negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.2 |
3.0 |
GO:0030033 |
microvillus assembly(GO:0030033) |
| 0.2 |
0.5 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.2 |
0.5 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.2 |
0.5 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.2 |
0.3 |
GO:0002489 |
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
| 0.2 |
1.0 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.2 |
0.2 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.2 |
0.5 |
GO:0030862 |
neuroblast division in subventricular zone(GO:0021849) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.2 |
0.2 |
GO:1905065 |
positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 0.2 |
1.0 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.2 |
0.3 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 0.2 |
0.7 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.2 |
0.5 |
GO:1904580 |
regulation of intracellular mRNA localization(GO:1904580) |
| 0.2 |
0.5 |
GO:1902741 |
type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.2 |
0.2 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.2 |
0.7 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.2 |
0.7 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.2 |
0.5 |
GO:0034035 |
sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.2 |
0.5 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.2 |
0.7 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.2 |
0.5 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.2 |
3.5 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.2 |
1.8 |
GO:0010955 |
negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.2 |
0.3 |
GO:0060126 |
somatotropin secreting cell differentiation(GO:0060126) |
| 0.2 |
0.2 |
GO:0097341 |
inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.2 |
0.3 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.2 |
4.0 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.2 |
1.0 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.2 |
0.3 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.2 |
0.3 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.2 |
0.2 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.2 |
1.5 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.2 |
1.5 |
GO:0070874 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.2 |
2.3 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.2 |
1.4 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.2 |
0.6 |
GO:1901525 |
negative regulation of macromitophagy(GO:1901525) |
| 0.2 |
0.6 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.2 |
1.3 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.2 |
1.3 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.2 |
0.8 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.2 |
0.5 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.2 |
0.5 |
GO:0007320 |
insemination(GO:0007320) |
| 0.2 |
0.8 |
GO:0044406 |
adhesion of symbiont to host(GO:0044406) |
| 0.2 |
4.8 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.2 |
0.2 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.2 |
0.6 |
GO:0032382 |
positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
| 0.2 |
0.9 |
GO:1903275 |
positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
| 0.2 |
0.6 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.2 |
0.5 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.2 |
1.5 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.2 |
0.6 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.2 |
0.3 |
GO:0051105 |
regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
| 0.2 |
0.8 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.2 |
0.3 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.2 |
0.6 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.2 |
0.2 |
GO:0070859 |
positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.2 |
0.2 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.1 |
2.1 |
GO:1901629 |
regulation of presynaptic membrane organization(GO:1901629) |
| 0.1 |
0.7 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.1 |
0.4 |
GO:0061370 |
testosterone biosynthetic process(GO:0061370) |
| 0.1 |
1.5 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.1 |
0.1 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.1 |
0.1 |
GO:0003284 |
septum primum development(GO:0003284) |
| 0.1 |
1.2 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.1 |
0.3 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.1 |
0.7 |
GO:1900169 |
regulation of glucocorticoid mediated signaling pathway(GO:1900169) negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.1 |
0.7 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.1 |
0.6 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) |
| 0.1 |
0.4 |
GO:0045144 |
meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
| 0.1 |
0.1 |
GO:0036466 |
synaptic vesicle recycling via endosome(GO:0036466) |
| 0.1 |
0.9 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.3 |
GO:0051311 |
meiotic metaphase plate congression(GO:0051311) |
| 0.1 |
1.0 |
GO:0042095 |
interferon-gamma biosynthetic process(GO:0042095) |
| 0.1 |
0.4 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.1 |
1.6 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 |
0.4 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.1 |
0.4 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 |
0.3 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.1 |
0.7 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.1 |
0.4 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.1 |
3.8 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.1 |
0.1 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
| 0.1 |
1.4 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
1.1 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.1 |
0.3 |
GO:0099624 |
atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.1 |
0.1 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.1 |
0.4 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.1 |
0.8 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.1 |
0.9 |
GO:0051256 |
mitotic spindle midzone assembly(GO:0051256) |
| 0.1 |
0.8 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.1 |
0.4 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 0.1 |
0.1 |
GO:0060681 |
branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.1 |
0.9 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.1 |
0.7 |
GO:0031442 |
positive regulation of mRNA 3'-end processing(GO:0031442) |
| 0.1 |
2.9 |
GO:0006336 |
DNA replication-independent nucleosome assembly(GO:0006336) |
| 0.1 |
0.3 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.1 |
0.7 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
1.4 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.1 |
0.5 |
GO:1900364 |
negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.1 |
1.7 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 |
0.3 |
GO:0019184 |
glutathione biosynthetic process(GO:0006750) nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.1 |
0.5 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 |
0.1 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.1 |
0.5 |
GO:0090472 |
dibasic protein processing(GO:0090472) |
| 0.1 |
0.9 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.1 |
1.0 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.1 |
0.3 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.1 |
0.1 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 |
1.7 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 |
0.5 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 |
0.5 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 |
0.4 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.1 |
0.5 |
GO:0050812 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.1 |
0.5 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.1 |
0.3 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.1 |
1.4 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
0.2 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.1 |
0.4 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.1 |
0.5 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 |
0.9 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.1 |
0.9 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.4 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.1 |
0.1 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.1 |
0.2 |
GO:0009814 |
defense response, incompatible interaction(GO:0009814) |
| 0.1 |
0.2 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.1 |
0.1 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 |
0.9 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.1 |
0.2 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.1 |
0.1 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.1 |
0.5 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
1.6 |
GO:0060416 |
response to growth hormone(GO:0060416) |
| 0.1 |
0.6 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
1.2 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.1 |
0.5 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.1 |
1.3 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.1 |
2.4 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.1 |
0.7 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
0.7 |
GO:0042754 |
negative regulation of circadian rhythm(GO:0042754) |
| 0.1 |
1.0 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.1 |
1.8 |
GO:0061756 |
leukocyte adhesion to vascular endothelial cell(GO:0061756) |
| 0.1 |
0.1 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.1 |
0.8 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
0.5 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 |
0.6 |
GO:0060631 |
regulation of meiosis I(GO:0060631) |
| 0.1 |
0.6 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 |
0.6 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 |
0.6 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 0.1 |
0.2 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.1 |
0.6 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.1 |
0.2 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 |
0.2 |
GO:2000659 |
regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.1 |
0.3 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.1 |
1.7 |
GO:0044253 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.1 |
0.9 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.1 |
0.1 |
GO:0010889 |
regulation of sequestering of triglyceride(GO:0010889) positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 |
0.1 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.1 |
0.2 |
GO:2000668 |
dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
| 0.1 |
0.1 |
GO:2000779 |
regulation of double-strand break repair(GO:2000779) |
| 0.1 |
0.3 |
GO:0060912 |
cardiac cell fate specification(GO:0060912) |
| 0.1 |
0.1 |
GO:0003161 |
cardiac conduction system development(GO:0003161) |
| 0.1 |
1.6 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.1 |
0.5 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.1 |
1.1 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 |
1.0 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
1.2 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 |
0.2 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.1 |
0.3 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
3.3 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.1 |
0.7 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
0.1 |
GO:0048793 |
pronephros development(GO:0048793) |
| 0.1 |
0.7 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
1.0 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) |
| 0.1 |
0.3 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.1 |
2.2 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.1 |
3.1 |
GO:0035019 |
somatic stem cell population maintenance(GO:0035019) |
| 0.1 |
0.4 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.1 |
0.1 |
GO:0072719 |
cellular response to cisplatin(GO:0072719) |
| 0.1 |
1.1 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.1 |
0.3 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.1 |
0.5 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.1 |
0.1 |
GO:0021648 |
vestibulocochlear nerve morphogenesis(GO:0021648) |
| 0.1 |
0.1 |
GO:0032415 |
regulation of sodium:proton antiporter activity(GO:0032415) |
| 0.1 |
0.9 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.1 |
0.2 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.1 |
1.3 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 |
0.3 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.1 |
GO:1903719 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.1 |
2.8 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.1 |
0.6 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.1 |
0.5 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.1 |
0.3 |
GO:0031590 |
wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.1 |
0.6 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 |
0.4 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.1 |
0.3 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.1 |
0.1 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.1 |
0.3 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 |
1.9 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 |
1.4 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
0.8 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.1 |
0.5 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.1 |
0.4 |
GO:0070460 |
thyroid-stimulating hormone secretion(GO:0070460) |
| 0.1 |
0.8 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
0.1 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 |
0.3 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 |
0.4 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 0.1 |
0.6 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.1 |
0.3 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.1 |
0.7 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
0.3 |
GO:0003345 |
proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
| 0.1 |
0.3 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.1 |
1.0 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.1 |
3.0 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.1 |
0.3 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 |
0.6 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
0.2 |
GO:0045006 |
DNA deamination(GO:0045006) |
| 0.1 |
0.3 |
GO:0034145 |
positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.1 |
0.7 |
GO:0014842 |
skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
| 0.1 |
1.8 |
GO:0042491 |
auditory receptor cell differentiation(GO:0042491) |
| 0.1 |
0.1 |
GO:0033273 |
response to vitamin(GO:0033273) |
| 0.1 |
0.6 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 |
0.5 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.1 |
0.1 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.1 |
0.9 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.1 |
0.2 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.1 |
1.0 |
GO:0006309 |
DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
| 0.1 |
0.3 |
GO:0010991 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 |
0.2 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.1 |
GO:0048209 |
regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
| 0.1 |
0.8 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 |
0.3 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.1 |
1.0 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.1 |
1.0 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.1 |
0.5 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 |
0.7 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.1 |
0.2 |
GO:0010831 |
positive regulation of myotube differentiation(GO:0010831) |
| 0.1 |
0.2 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
1.2 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.1 |
0.8 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.1 |
0.6 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.1 |
0.4 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.3 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 0.1 |
0.8 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) |
| 0.1 |
0.3 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.1 |
0.4 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
0.2 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 |
1.7 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 |
0.2 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 |
0.6 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
0.5 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 0.1 |
1.0 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.1 |
0.4 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
0.2 |
GO:0035826 |
rubidium ion transport(GO:0035826) |
| 0.1 |
0.2 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
0.5 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
0.3 |
GO:1990046 |
positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 0.1 |
0.3 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.1 |
0.2 |
GO:1902527 |
positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 |
0.3 |
GO:0071360 |
cellular response to exogenous dsRNA(GO:0071360) |
| 0.1 |
0.2 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.1 |
0.2 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.1 |
0.7 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.1 |
0.2 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.1 |
0.2 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 |
0.1 |
GO:0045005 |
DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.1 |
0.2 |
GO:0071211 |
protein targeting to vacuole involved in autophagy(GO:0071211) |
| 0.1 |
1.2 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.1 |
0.6 |
GO:2000794 |
regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
| 0.1 |
1.4 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.1 |
0.2 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 |
0.4 |
GO:0051307 |
meiotic chromosome separation(GO:0051307) |
| 0.1 |
0.6 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.1 |
5.4 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.1 |
0.3 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.1 |
0.2 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 |
0.6 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
0.5 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 |
0.3 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
1.0 |
GO:0008105 |
asymmetric protein localization(GO:0008105) |
| 0.1 |
0.8 |
GO:0016101 |
diterpenoid metabolic process(GO:0016101) |
| 0.1 |
0.1 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 0.1 |
0.6 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.4 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 |
0.4 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.1 |
0.5 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 |
0.6 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
0.2 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 0.1 |
0.1 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.1 |
0.5 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.1 |
0.2 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.1 |
0.2 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.1 |
0.2 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.1 |
0.4 |
GO:0016233 |
telomere capping(GO:0016233) |
| 0.1 |
0.3 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 |
0.1 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.1 |
0.3 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.1 |
0.2 |
GO:0046549 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 |
0.2 |
GO:1904468 |
negative regulation of tumor necrosis factor secretion(GO:1904468) |
| 0.1 |
0.6 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
0.4 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
0.4 |
GO:1990839 |
response to endothelin(GO:1990839) |
| 0.1 |
0.1 |
GO:0021940 |
positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.1 |
0.4 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.1 |
0.1 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.1 |
0.1 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
3.0 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.1 |
0.6 |
GO:0031272 |
regulation of pseudopodium assembly(GO:0031272) |
| 0.1 |
0.6 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 |
0.8 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.1 |
0.2 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.1 |
1.4 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.1 |
0.4 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.1 |
0.3 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.1 |
0.4 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.1 |
0.2 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 |
0.1 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 |
0.1 |
GO:0002585 |
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.1 |
0.3 |
GO:0071351 |
interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.1 |
0.1 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 |
0.3 |
GO:0031123 |
RNA 3'-end processing(GO:0031123) |
| 0.1 |
0.1 |
GO:1900118 |
negative regulation of execution phase of apoptosis(GO:1900118) |
| 0.1 |
0.3 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.1 |
0.2 |
GO:0006586 |
tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
| 0.1 |
0.3 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.1 |
1.1 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.1 |
0.5 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.1 |
0.7 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.1 |
0.1 |
GO:0090649 |
rRNA export from nucleus(GO:0006407) response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.1 |
1.0 |
GO:0097502 |
mannosylation(GO:0097502) |
| 0.1 |
0.3 |
GO:0006777 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 |
0.6 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.1 |
0.2 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 |
0.1 |
GO:0045629 |
negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.1 |
0.7 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.1 |
0.6 |
GO:0051972 |
regulation of telomerase activity(GO:0051972) |
| 0.1 |
0.3 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.1 |
0.1 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.1 |
1.0 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
0.4 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.1 |
0.3 |
GO:0070162 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 |
1.2 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.1 |
0.1 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.1 |
0.2 |
GO:0090004 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.1 |
0.6 |
GO:0044818 |
mitotic G2/M transition checkpoint(GO:0044818) |
| 0.1 |
0.6 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.1 |
0.1 |
GO:1904504 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.1 |
0.1 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.1 |
1.0 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.5 |
GO:0007569 |
cell aging(GO:0007569) |
| 0.1 |
0.1 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 |
1.2 |
GO:0072698 |
protein localization to microtubule cytoskeleton(GO:0072698) |
| 0.1 |
1.0 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.1 |
0.4 |
GO:0015862 |
uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
| 0.1 |
0.1 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.1 |
0.2 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.1 |
0.2 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.3 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.1 |
0.2 |
GO:1902170 |
cellular response to reactive nitrogen species(GO:1902170) |
| 0.1 |
0.1 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.1 |
0.5 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
1.7 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.1 |
0.5 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.1 |
0.5 |
GO:0003148 |
outflow tract septum morphogenesis(GO:0003148) |
| 0.1 |
0.8 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 |
0.3 |
GO:0034116 |
positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.1 |
1.0 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 |
1.2 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 |
0.2 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.2 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 |
2.0 |
GO:0000281 |
mitotic cytokinesis(GO:0000281) |
| 0.1 |
0.1 |
GO:0001798 |
type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type I hypersensitivity(GO:0001812) type II hypersensitivity(GO:0002445) positive regulation of hypersensitivity(GO:0002885) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.1 |
0.2 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.1 |
0.2 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
0.3 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 |
0.2 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 |
0.1 |
GO:0060594 |
mammary gland specification(GO:0060594) |
| 0.1 |
0.6 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.2 |
GO:0016093 |
polyprenol metabolic process(GO:0016093) |
| 0.1 |
0.7 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.1 |
0.4 |
GO:0045830 |
positive regulation of isotype switching(GO:0045830) |
| 0.1 |
0.6 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.1 |
0.2 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) |
| 0.1 |
0.4 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
1.6 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.1 |
0.1 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.1 |
0.3 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.1 |
0.2 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.1 |
0.4 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.1 |
0.8 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 |
0.2 |
GO:0060768 |
epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
| 0.1 |
0.1 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.1 |
0.4 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
0.4 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.4 |
GO:2001198 |
regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.1 |
0.2 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 |
0.1 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 |
0.1 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
0.2 |
GO:0061085 |
regulation of histone H3-K27 methylation(GO:0061085) |
| 0.1 |
0.1 |
GO:0042226 |
interleukin-6 biosynthetic process(GO:0042226) regulation of interleukin-6 biosynthetic process(GO:0045408) positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.1 |
0.1 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.1 |
0.5 |
GO:1903077 |
negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.1 |
0.1 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
0.1 |
GO:0060601 |
lateral sprouting from an epithelium(GO:0060601) |
| 0.1 |
0.1 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.1 |
1.5 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.1 |
0.6 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
2.3 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.0 |
0.4 |
GO:0032288 |
myelin assembly(GO:0032288) |
| 0.0 |
0.3 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.0 |
0.0 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.0 |
0.3 |
GO:0033194 |
response to hydroperoxide(GO:0033194) |
| 0.0 |
0.1 |
GO:0061365 |
positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.0 |
0.2 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 |
0.4 |
GO:0001773 |
myeloid dendritic cell activation(GO:0001773) |
| 0.0 |
0.1 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.0 |
0.3 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.0 |
0.1 |
GO:1903422 |
negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.0 |
0.4 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.0 |
0.3 |
GO:1903337 |
positive regulation of vacuolar transport(GO:1903337) |
| 0.0 |
0.1 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.0 |
0.2 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.0 |
0.5 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.0 |
0.1 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.0 |
0.3 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
0.3 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
0.2 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.0 |
0.3 |
GO:0050872 |
white fat cell differentiation(GO:0050872) |
| 0.0 |
0.3 |
GO:0098964 |
dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
| 0.0 |
0.1 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.0 |
0.4 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.0 |
0.1 |
GO:0045624 |
positive regulation of T-helper cell differentiation(GO:0045624) |
| 0.0 |
0.0 |
GO:1903753 |
negative regulation of p38MAPK cascade(GO:1903753) |
| 0.0 |
0.3 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.0 |
0.2 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.0 |
0.1 |
GO:0019732 |
antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
| 0.0 |
0.2 |
GO:0071459 |
protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
| 0.0 |
0.1 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.0 |
0.7 |
GO:0007606 |
sensory perception of chemical stimulus(GO:0007606) |
| 0.0 |
0.2 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 |
0.1 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.0 |
0.1 |
GO:1901679 |
nucleotide transmembrane transport(GO:1901679) |
| 0.0 |
0.1 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.0 |
0.5 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.0 |
0.4 |
GO:0048854 |
brain morphogenesis(GO:0048854) |
| 0.0 |
0.4 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.0 |
0.0 |
GO:0043137 |
DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
| 0.0 |
0.1 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.0 |
0.1 |
GO:0033087 |
negative regulation of immature T cell proliferation(GO:0033087) |
| 0.0 |
0.1 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.0 |
0.7 |
GO:2000772 |
regulation of cellular senescence(GO:2000772) |
| 0.0 |
0.1 |
GO:1903371 |
regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.0 |
0.6 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.0 |
0.1 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 0.0 |
0.2 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.0 |
0.1 |
GO:0034134 |
toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.0 |
0.1 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.0 |
0.2 |
GO:0045187 |
regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.0 |
0.2 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.0 |
0.3 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.0 |
0.3 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.0 |
0.2 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.0 |
0.1 |
GO:0032621 |
interleukin-18 production(GO:0032621) |
| 0.0 |
0.5 |
GO:0002066 |
columnar/cuboidal epithelial cell development(GO:0002066) |
| 0.0 |
0.0 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.0 |
0.4 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 |
0.1 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.0 |
0.2 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.0 |
0.1 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.0 |
0.1 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.0 |
0.3 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 |
0.1 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.0 |
0.7 |
GO:0014002 |
astrocyte development(GO:0014002) |
| 0.0 |
0.0 |
GO:0098869 |
cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
| 0.0 |
0.1 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 |
0.6 |
GO:0034629 |
cellular protein complex localization(GO:0034629) |
| 0.0 |
0.1 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.0 |
0.2 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.0 |
0.1 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.0 |
0.3 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.0 |
0.1 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.3 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.3 |
GO:0061368 |
maternal process involved in parturition(GO:0060137) behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) modification of postsynaptic actin cytoskeleton(GO:0098885) |
| 0.0 |
0.2 |
GO:0051569 |
regulation of histone H3-K4 methylation(GO:0051569) |
| 0.0 |
0.8 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.0 |
0.3 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 |
0.6 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.1 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.0 |
0.2 |
GO:0008655 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.0 |
0.8 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.0 |
0.3 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 |
0.1 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.0 |
0.2 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.0 |
0.7 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.1 |
GO:1903756 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) positive regulation of dendritic spine maintenance(GO:1902952) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.0 |
0.2 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.0 |
0.2 |
GO:0006868 |
glutamine transport(GO:0006868) |
| 0.0 |
0.1 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.2 |
GO:1900426 |
positive regulation of defense response to bacterium(GO:1900426) |
| 0.0 |
0.5 |
GO:0051647 |
nucleus localization(GO:0051647) |
| 0.0 |
0.1 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.0 |
0.2 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.5 |
GO:0090224 |
regulation of spindle organization(GO:0090224) |
| 0.0 |
0.4 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.0 |
1.5 |
GO:0006893 |
Golgi to plasma membrane transport(GO:0006893) |
| 0.0 |
0.1 |
GO:0018022 |
peptidyl-lysine methylation(GO:0018022) |
| 0.0 |
0.3 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 |
0.1 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.0 |
0.2 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 |
0.1 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.0 |
0.1 |
GO:1903817 |
negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.0 |
0.3 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.3 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.0 |
0.1 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.0 |
0.2 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.0 |
0.3 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.0 |
0.1 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.0 |
0.2 |
GO:1900086 |
regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 0.0 |
0.3 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.0 |
0.0 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.0 |
0.4 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
1.2 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.0 |
0.2 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.0 |
0.1 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.0 |
0.2 |
GO:0055090 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.0 |
0.1 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.0 |
0.2 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.0 |
0.2 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.0 |
0.4 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.0 |
0.2 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.0 |
0.1 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.0 |
0.1 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.0 |
0.7 |
GO:0070303 |
negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.0 |
0.4 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.0 |
1.0 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 |
0.1 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.0 |
0.1 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 |
0.1 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.0 |
0.0 |
GO:1901856 |
negative regulation of cellular respiration(GO:1901856) |
| 0.0 |
0.2 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.0 |
0.0 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.1 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.0 |
0.2 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.0 |
0.1 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.0 |
0.1 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 |
0.1 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.0 |
0.5 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.1 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.0 |
0.2 |
GO:0042532 |
negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.0 |
0.2 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.0 |
0.7 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
0.2 |
GO:0032608 |
interferon-beta production(GO:0032608) |
| 0.0 |
0.2 |
GO:0009437 |
carnitine metabolic process(GO:0009437) |
| 0.0 |
0.3 |
GO:1901620 |
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
| 0.0 |
0.9 |
GO:0007601 |
visual perception(GO:0007601) |
| 0.0 |
0.3 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.2 |
GO:0051084 |
'de novo' posttranslational protein folding(GO:0051084) |
| 0.0 |
0.1 |
GO:0051176 |
positive regulation of sulfur metabolic process(GO:0051176) |
| 0.0 |
0.4 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.0 |
0.7 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
| 0.0 |
0.2 |
GO:0034242 |
negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
| 0.0 |
0.3 |
GO:0030879 |
mammary gland development(GO:0030879) |
| 0.0 |
0.0 |
GO:1901098 |
positive regulation of autophagosome maturation(GO:1901098) |
| 0.0 |
0.4 |
GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.0 |
0.2 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
0.3 |
GO:0035384 |
acetyl-CoA biosynthetic process(GO:0006085) thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
| 0.0 |
0.0 |
GO:0002765 |
immune response-inhibiting signal transduction(GO:0002765) |
| 0.0 |
0.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.1 |
GO:0000288 |
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
| 0.0 |
0.9 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 |
0.1 |
GO:0060312 |
regulation of blood vessel remodeling(GO:0060312) |
| 0.0 |
0.1 |
GO:0060042 |
retina morphogenesis in camera-type eye(GO:0060042) |
| 0.0 |
0.0 |
GO:0032497 |
detection of lipopolysaccharide(GO:0032497) |
| 0.0 |
0.1 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.0 |
0.2 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.0 |
0.0 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.0 |
0.1 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.0 |
0.5 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.0 |
0.1 |
GO:0006555 |
methionine metabolic process(GO:0006555) |
| 0.0 |
0.0 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.0 |
0.2 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.0 |
0.1 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.0 |
0.3 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.0 |
0.1 |
GO:0006172 |
ADP biosynthetic process(GO:0006172) |
| 0.0 |
0.2 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.0 |
GO:0010920 |
negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
| 0.0 |
0.1 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.0 |
0.2 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.0 |
0.3 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.0 |
0.2 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.0 |
0.3 |
GO:0051570 |
regulation of histone H3-K9 methylation(GO:0051570) |
| 0.0 |
0.1 |
GO:0034285 |
response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.0 |
0.9 |
GO:0006261 |
DNA-dependent DNA replication(GO:0006261) |
| 0.0 |
0.0 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 0.0 |
0.2 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.0 |
0.0 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 |
0.0 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.0 |
0.2 |
GO:0009226 |
nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.0 |
0.0 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.0 |
0.2 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.0 |
0.1 |
GO:0042795 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 |
0.1 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.0 |
0.4 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.0 |
0.2 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.0 |
0.2 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.0 |
0.0 |
GO:0043320 |
natural killer cell degranulation(GO:0043320) |
| 0.0 |
0.0 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.0 |
0.1 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.0 |
0.1 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 |
0.0 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.0 |
0.4 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.0 |
0.1 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.0 |
0.1 |
GO:0015744 |
succinate transport(GO:0015744) |
| 0.0 |
0.0 |
GO:0030825 |
positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.0 |
0.1 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.0 |
0.2 |
GO:0086036 |
regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.0 |
0.0 |
GO:0002328 |
pro-B cell differentiation(GO:0002328) |
| 0.0 |
0.0 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.0 |
0.1 |
GO:0043045 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.0 |
0.1 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 |
0.3 |
GO:0003382 |
epithelial cell morphogenesis(GO:0003382) |
| 0.0 |
0.0 |
GO:0048208 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.0 |
0.5 |
GO:0042633 |
molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.0 |
0.0 |
GO:0044532 |
modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
| 0.0 |
0.1 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 0.0 |
0.0 |
GO:0060390 |
regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.0 |
0.2 |
GO:0033143 |
regulation of intracellular steroid hormone receptor signaling pathway(GO:0033143) |
| 0.0 |
0.4 |
GO:0000910 |
cytokinesis(GO:0000910) |
| 0.0 |
0.0 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.0 |
0.0 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.0 |
0.1 |
GO:0030007 |
cellular potassium ion homeostasis(GO:0030007) |
| 0.0 |
0.0 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.0 |
0.0 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.0 |
0.0 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.0 |
0.0 |
GO:0042501 |
serine phosphorylation of STAT protein(GO:0042501) |
| 0.0 |
0.0 |
GO:0003283 |
atrial septum development(GO:0003283) |
| 0.0 |
0.0 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.0 |
0.2 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.2 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.0 |
0.1 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.0 |
0.2 |
GO:0043631 |
RNA polyadenylation(GO:0043631) |
| 0.0 |
0.0 |
GO:0071320 |
cellular response to cAMP(GO:0071320) |
| 0.0 |
0.0 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.0 |
0.1 |
GO:0031952 |
regulation of protein autophosphorylation(GO:0031952) |
| 0.0 |
0.0 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.0 |
0.1 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.0 |
0.1 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.0 |
0.1 |
GO:0042438 |
melanin biosynthetic process(GO:0042438) |
| 0.0 |
0.0 |
GO:0033004 |
negative regulation of mast cell activation(GO:0033004) |
| 0.0 |
0.0 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.0 |
0.0 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.0 |
0.0 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.0 |
GO:0009071 |
serine family amino acid catabolic process(GO:0009071) |
